Correlation Between Safe and Qualigen Therapeutics
Can any of the company-specific risk be diversified away by investing in both Safe and Qualigen Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Safe and Qualigen Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Safe and Green and Qualigen Therapeutics, you can compare the effects of market volatilities on Safe and Qualigen Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Safe with a short position of Qualigen Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Safe and Qualigen Therapeutics.
Diversification Opportunities for Safe and Qualigen Therapeutics
0.74 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Safe and Qualigen is 0.74. Overlapping area represents the amount of risk that can be diversified away by holding Safe and Green and Qualigen Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Qualigen Therapeutics and Safe is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Safe and Green are associated (or correlated) with Qualigen Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Qualigen Therapeutics has no effect on the direction of Safe i.e., Safe and Qualigen Therapeutics go up and down completely randomly.
Pair Corralation between Safe and Qualigen Therapeutics
Considering the 90-day investment horizon Safe and Green is expected to under-perform the Qualigen Therapeutics. In addition to that, Safe is 1.03 times more volatile than Qualigen Therapeutics. It trades about -0.06 of its total potential returns per unit of risk. Qualigen Therapeutics is currently generating about -0.04 per unit of volatility. If you would invest 2,500 in Qualigen Therapeutics on December 3, 2024 and sell it today you would lose (2,179) from holding Qualigen Therapeutics or give up 87.16% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Safe and Green vs. Qualigen Therapeutics
Performance |
| Timeline |
| Safe and Green |
| Qualigen Therapeutics |
Safe and Qualigen Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Safe and Qualigen Therapeutics
The main advantage of trading using opposite Safe and Qualigen Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Safe position performs unexpectedly, Qualigen Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Qualigen Therapeutics will offset losses from the drop in Qualigen Therapeutics' long position.The idea behind Safe and Green and Qualigen Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Qualigen Therapeutics vs. ZyVersa Therapeutics | ||
| Qualigen Therapeutics vs. Immix Biopharma | ||
| Qualigen Therapeutics vs. Phio Pharmaceuticals Corp | ||
| Qualigen Therapeutics vs. 180 Life Sciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Complementary Tools
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |